Both in Pharmaceuticals
Kailera Therapeutics vs Ultragenyx Pharmaceutical
Over the past year KLRA returned −9.8% and RARE returned +16.3%; their daily moves had a correlation of 0.30.
KLRA −9.8% RARE +16.3%Growth of $1, one year, split-adjusted
| Metric | KLRA | RARE |
|---|---|---|
| Price | $12.58 | $16.63 |
| Market cap | $1.63B | $1.64B |
| Today | +3.54% | +2.02% |
| 1 month | +16.1% | +14.7% |
| 6 months | — | −33.5% |
| Year to date | — | −27.7% |
| 1 year | — | −51.9% |
| Revenue growth (YoY) | — | +28.1% |
| Gross margin | — | 84.1% |
| Net margin | — | −43.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.3× |
| Net cash | $916.7M | $292.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 128.3% |
| Short % of float | 9.1% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).